Farzin Irani1, Jordan Mark Barbone1, Janet Beausoleil2, Lynn Gerald3,4. 1. a Department of Psychology , West Chester University of Pennsylvania , West Chester , PA , USA. 2. b Division of Allergy and Immunology , The Children's Hospital of Philadelphia , Philadelphia , PA , USA. 3. c Mel and Enid Zuckerman College of Public Health , University of Arizona , Tucson , AZ , USA. 4. d Asthma and Airways Disease Research Center , University of Arizona , Tucson , AZ , USA.
Abstract
INTRODUCTION: Asthma is a chronic disease with significant health burden and socioeconomic and racial/ethnic disparities related to diagnosis and treatment. Asthma primarily affects the lungs, but can impact brain function through direct and indirect mechanisms. Some studies have suggested that asthma negatively impacts cognition, while others have failed to identify asthma-related cognitive compromise. We aimed to conduct a meta-analysis of cognition in individuals with asthma compared to that in healthy controls. We also examined the impact of some key potential moderators. METHOD: Data on cognitive outcome measures and sociodemographic, illness-related, and study-related variables were extracted from studies reporting cognitive test performance in individuals with asthma compared to that in controls. RESULTS: There was no evidence of publication bias. A random-effects model examining differences in task performance between 2017 individuals with asthma and 2131 healthy controls showed significant effects in the small to medium range. Cognitive deficits associated with asthma were global, with strongest effects on broader measures involving academic achievement and executive functioning, but with additional impact on processing speed, global intellect, attention, visuospatial functioning, language, learning, and memory. Severity of asthma was a key moderator, with greatest cognitive deficits associated with severe asthma. Cognitive burden was also greatest in asthma patients who were younger, males, from low socioeconomic backgrounds, and from racial/ethnic minorities. Effects were independent of type of population (child versus adult), type of study (norm-referenced versus control-referenced), or reported use of oral or inhaled corticosteroid medications. CONCLUSIONS: There is cognitive burden associated with asthma, particularly among vulnerable groups with severe asthma. This could be due to increased risk of intermittent cerebral hypoxia in severe asthma. The clinical need to assess cognition in individuals with asthma is underscored.
INTRODUCTION:Asthma is a chronic disease with significant health burden and socioeconomic and racial/ethnic disparities related to diagnosis and treatment. Asthma primarily affects the lungs, but can impact brain function through direct and indirect mechanisms. Some studies have suggested that asthma negatively impacts cognition, while others have failed to identify asthma-related cognitive compromise. We aimed to conduct a meta-analysis of cognition in individuals with asthma compared to that in healthy controls. We also examined the impact of some key potential moderators. METHOD: Data on cognitive outcome measures and sociodemographic, illness-related, and study-related variables were extracted from studies reporting cognitive test performance in individuals with asthma compared to that in controls. RESULTS: There was no evidence of publication bias. A random-effects model examining differences in task performance between 2017 individuals with asthma and 2131 healthy controls showed significant effects in the small to medium range. Cognitive deficits associated with asthma were global, with strongest effects on broader measures involving academic achievement and executive functioning, but with additional impact on processing speed, global intellect, attention, visuospatial functioning, language, learning, and memory. Severity of asthma was a key moderator, with greatest cognitive deficits associated with severe asthma. Cognitive burden was also greatest in asthmapatients who were younger, males, from low socioeconomic backgrounds, and from racial/ethnic minorities. Effects were independent of type of population (child versus adult), type of study (norm-referenced versus control-referenced), or reported use of oral or inhaled corticosteroid medications. CONCLUSIONS: There is cognitive burden associated with asthma, particularly among vulnerable groups with severe asthma. This could be due to increased risk of intermittent cerebral hypoxia in severe asthma. The clinical need to assess cognition in individuals with asthma is underscored.
Authors: Ajay Kumar Nair; Carol A Van Hulle; Barbara B Bendlin; Henrik Zetterberg; Kaj Blennow; Norbert Wild; Gwendlyn Kollmorgen; Ivonne Suridjan; William W Busse; Melissa A Rosenkranz Journal: Alzheimers Dement (N Y) Date: 2022-07-08
Authors: Fabian Schwimmbeck; Wolfgang Staffen; Christopher Höhn; Fabio Rossini; Nora Renz; Markus Lobendanz; Peter Reichenpfader; Bernhard Iglseder; Ludwig Aigner; Eugen Trinka; Yvonne Höller Journal: Brain Sci Date: 2021-04-27
Authors: Josef Sucec; Michaela Herzog; Omer Van den Bergh; Ilse Van Diest; Andreas von Leupoldt Journal: Front Physiol Date: 2019-05-28 Impact factor: 4.566
Authors: Jacqueline H Becker; Jonathan M Feldman; Arushi Arora; Paula J Busse; Juan P Wisnivesky; Alex D Federman Journal: J Asthma Date: 2020-12-07 Impact factor: 2.515
Authors: Juliet L Kroll; Ashton M Steele; Amy E Pinkham; Changho Choi; David A Khan; Sheenal V Patel; Justin R Chen; Sina Aslan; E Sherwood Brown; Thomas Ritz Journal: Neuroimage Clin Date: 2018-04-12 Impact factor: 4.881
Authors: Cecilia Lundholm; Bronwyn K Brew; Brian M D'Onofrio; Emma Caffrey Osvald; Henrik Larsson; Catarina Almqvist Journal: Sci Rep Date: 2020-05-06 Impact factor: 4.379